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Introduction
Musculoskeletal injuries are highly prevalent in civilian 
and military trauma and can impart permanent disability1,2. 
A volumetric loss of muscle tissue adjacent to fractured bone 
is frequently encountered (e.g., type IIIa/b open fracture). 
Volumetric muscle loss (VML) injuries are irrecoverable 
in humans and animal models- owing to the complete loss 
of crucial elements for skeletal muscle regeneration. Since 
there are no therapies clinically available that can regenerate 
the lost musculature, VML is often untreated and considered 
part of the natural sequelae of trauma. As a result, VML inju-
ry manifests a permanent loss of contractile tissue, extensive 
fibrosis, and a chronic loss of function3-7, which may directly 
lead to disability in open fracture patients8 that may progres-
sively worsen with time9. 
While VML injuries result in chronic reduction of limb func-
tional capacity, acutely after trauma these severe muscle 
injuries may also impair healing of adjacent fractured bone. 
This is exemplified by the clinical grading of open fractures 
whereby severe fracture with predictably worse healing out-
comes are predicated on the extent of surrounding soft tissue 
comorbidity10. In some of these cases (e.g., type IIIb), free or 
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rotational muscle flaps are transferred to the site of VML, sig-
nifying the importance of restoring muscle-bone interactions 
to fracture healing. In support of clinical observations, animal 
models have unequivocally demonstrated that the loss of ad-
jacent musculature impairs fracture healing. For instance, a 
series of studies performed in a rat self-healing tibia fracture 
model demonstrated that tibialis anterior (TA) muscle abla-
tion delayed recovery of tibia mechanical properties11-13. Ad-
ditionally, in a rat femur critical size defect model, adjacent 
quadriceps VML (~10% loss of muscle) impaired rhBMP-2 
mediated fracture healing14. Lastly, in a mouse simple frac-
ture model TA muscle dissection and further isolation of the 
fracture site from the posterior musculature impaired frac-
ture healing15. All told, it is clear that the traumatic or surgical 
loss of surrounding musculature has a deleterious effect on 
fracture healing. 
Mechanisms bridging VML with compromised bone heal-
ing intuitively involve compromised regional blood flow, but 
also may be affected by localized VML-associated effects on 
fracture inflammation. Dysregulated inflammation is asso-
ciated with diminished bone strength and impaired fracture 
healing. For example, disease conditions that present chronic 
systemic inflammation, such as diabetes mellitus, inflamma-
tory bowel syndrome, and rheumatoid arthritis are associ-
ated with increased susceptibility to fracture16-19. Moreover, 
elevated systemic inflammation following polytrauma (e.g., 
fracture concomitant with blunt chest trauma) has been as-
sociated with delayed fractured healing20,21. Notably, there is 
also evidence that local muscle inflammation may also medi-
ate fracture healing. In a mouse model of Duchenne muscu-
lar dystrophy, dystrophin deficiency results in chronic mus-
cle inflammation, diminished bone strength, and impaired 
fracture healing22-24. To date very little is understood of the 
immune response to traumatic VML injury and its potential 
role in local musculoskeletal healing. Therefore, the purpose 
of this study was to characterize the immune response to 
VML injury and to assess whether concomitant VML altered 
macrophage or T-lymphocyte cellular infiltration within an 
adjacent diaphyseal fracture in a rat muscle-bone composite 
injury model that presents VML-dependent delayed fracture 
healing.
Materials and methods
Surgical protocol 
All animal procedures were approved by the Institutional 
Animal Care and Use Committee and were conducted in com-
pliance with the Animal Welfare Act and in accordance with 
the principles of the Guide for the Care and Use of Laboratory 
Animals. Inbred male Lewis rats (350-400 g) were housed 
in a specific-pathogen-free animal facility at the US Army In-
stitute of Surgical Research. Rats underwent an osteotomy 
(OST) and, to create an open fracture in selected groups, a 
volumetric muscle loss injury (OST+VML) as described else-
where5. Briefly, rats were anesthetized and a longitudinal 
incision was made along the lateral aspect of the leg and 
the skin and fascia covering the tibialis anterior (TA) muscle 
were bluntly separated from the underlying musculature. The 
tissue covering the middle third of the tibia was separated 
bluntly from the bone. An osteotomy was performed approxi-
mately 5 mm proximal to the tibia-fibula junction and stabi-
lized with a 1.25 mm Kirschner pin inserted in the medullary 
cavity from the tibial plateau. To surgically create a volumet-
ric muscle loss, the TA muscle and underlying extensor digi-
torum longus (EDL) muscle were separated using blunt dis-
section and a punch biopsy (6 mm) was executed through the 
middle third of the TA muscle and the tissue was removed, as 
we have previously reported3,5. Controls consisted of either 
naïve housing controls or sham surgery animals that under-
went all surgical procedures except osteotomy or VML (n=3-
6 per group). 
Micro-computed tomography
Microcomputed tomography (μCT) scans (Viva-CT40, 
Scanco Medical) were performed on a set of rat tibias at 
28d post-injury. Osteotomy regions were scanned at me-
dium resolution with a 21 μm voxel size at a voltage of 55 
kVp and a current of 145 μA. A volume of interest of 400 
slices was analyzed (~8.4 mm) with a centralized osteotomy 
site. Bone and callus were segmented by applying a thresh-
old corresponding to 455 mg hydroxyapatite/cm3 and a low-
pass Gaussian filter (sigma=1.2, support=1.0) was applied to 
suppress noise. Contours were first drawn around the entire 
specimen to obtain a total volume and then drawn around the 
cortical bone to obtain bone (original) volume. Callus volume 
was calculated by subtracting bone (original) volume from to-
tal volume, expressed as mm3. 
Three-point bending mechanical testing
Three-point bending was performed on a set of rat tibi-
as at 28d post-injury. For these samples, after harvesting, 
bones were stripped of muscles and adjoined fibulas, and 
placed in phosphate buffered saline (PBS). To eliminate any 
equipment variability, all samples were frozen at -80°C until 
testing could be performed at one time. Prior to mechanical 
testing, samples were thawed in a water bath at 37°C for ap-
proximately 1 hour. Briefly, tibias were placed in a materials 
bending system (Lloyd LRX) along the sagittal plane, with the 
medial (flat) portion of the tibia resting on the lower points, 
separated by 20 mm. Samples were deflected by lowering 
the apparatus at the midpoint of the lateral side of the bone. 
Samples were loaded at a constant speed of 2 mm/min until 
failure. Tibias from contralateral legs (without injury) were 
tested as controls. Load-deflection curves were used to ob-
tain maximum load (N) and stiffness (N/mm). 
TA muscle histology
Comparative histopathology and immunofluorescence 
staining methods were conducted with tissue sections from 
the middle third of the TA muscle that comprised the VML 
defect as well as bone tissue. TA muscle tissue isolation and 
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freezing was performed as described previously3,5. Tissue 
sections (10 μm thickness) were stained with hematoxylin 
and eosin (H&E) by standard procedure or probed for laminin, 
CD68, and nuclei (DAPI) using previously reported method-
ology3,5. Composite images of the complete TA muscle were 
acquired using Axio Scan.Z1 microscope (Zeiss) and ZEN 
imaging software (Zeiss). Sections were also examined by 
brightfield and fluorescence microscopy (Olympus IX71) and 
images of muscle tissue were acquired and analyzed using 
cellSens Standard software (Ver 1.4.1, Olympus). 
Real-time PCR
RNA was extracted from the muscle defect as previously 
described3. Briefly, the defect was excised and flash frozen in 
liquid nitrogen. Approximately 50 mg of muscle tissue was 
removed and homogenized. RNA was isolated using TRIzol 
and purified using an RNeasy Mini Kit (Qiagen) per manu-
facturer’s protocol. RNA was converted into complementary 
DNA (cDNA) using RT2 First Strand Kit (Qiagen). A vendor-
designed RT2 Profiler PCR array (PARN052Z, SABioscienc-
es) with was employed to examine rat innate and adaptive 
immune responses. Custom designed primers (Sigma-Al-
drich) with the sequences presented in Table 1 were used for 
select genes. A C1000 Touch Thermo Cycler equipped with 
a CFX96 Real-Time System (BioRad) was used to determine 
gene expression. Data analysis was carried out either with 
the RT2 Profiler PCR Array Data Analysis version 3.5 or ex-
pression levels for each mRNA transcript were determined 
by the 2-ΔΔCT method. Gene expression in OST+VML muscle 
tissue was relative to expression in contralateral control 
muscle tissue and normalized to reference gene, Rplp1 or 
Rn18s (n=3-6 per group).
Isolation of cellular infiltrates from muscle defect
Cells were isolated from complete TA muscle defect by en-
zymatic digestion. The defect was surgically isolated and the 
mass was determined. In 1.5 ml tubes, tissue was incubated 
with 1% collagenase type II and 2.4 U/mL of dispase dis-
solved in phosphate buffered saline (PBS) plus 2.5 mM cal-
cium chloride for 90 minutes at 37°C. Following enzymatic 
digestion, cells were further released in a tissue culture plate 
containing RPMI 1640 media plus L-glutamine and 5% heat-
inactivated fetal bovine serum (FBS) by gentle mechanical 
disruption using the back of a sterile 3-ml syringe plunger 
and filtered through a cell strainer (70 μm pore size). Eryth-
rocytes were lysed with ammonium-chloride-potassium 
(ACK) lysing buffer and cells were pelleted by centrifugation 
at 1500 RPM for 10 min, 4oC. Cells were subsequently fil-
tered through a cell strainer (40 μm pore size), washed, and 
resuspended in wash buffer that consisted of PBS containing 
0.5% FBS and 0.1% sodium azide. Viable cells were visual-
ized by trypan blue exclusion and quantified by light micros-
copy using a hemocytometer. 
Quantification of cellular infiltrates in muscle defect
Approximately 2-4 x 105 cells were incubated with anti-
CD32 antibody to block Fc receptors. Cells were washed and 
then labeled for 30 min with one of two cocktails of fluoro-
chrome-conjugated monoclonal antibodies described in Ta-
ble 2 to identify myeloid cells or T lymphocytes. The myeloid 
cell cocktail included anti-CD45, anti-CD11b, anti-CD86, and 
anti-CD163. The T lymphocyte cell cocktail consisted of anti-
CD3, anti-CD4, and anti-CD8α. Labeled cells were washed 
twice and fixed with 1% paraformaldehyde. Labeled cells 
(100,000 or 200,000 cells per myeloid or lymphoid sam-
ples, respectively) were enumerated by fluorescence-activat-
ed cells sorting (FACS) using a MACSQuant flow cytometer 
(Miltenyi Biotec). Data were analyzed using MACSQuantify 
software (Miltenyi Biotec). Gating strategies to identify cellu-
Forward sequence Reverse sequence Amplicon length, bp
ARG1 5’-GTGAAGAACCCACGGTCTGT-3’ 5’-GTGAGCATCCACCCAAATG-3’ 180
CCR7 5’-GCTCTCCTGGTCATTTTCCA-3’ 5’-AAGCACACCGACTCATACAGG-3’ 107
CD163 5’-TCATTTCGAAGAAGCCCAAG-3’ 5’-CTCCGTGTTTCACTTCCACA-3’ 101
iNOS 5’-ACTGTGTGCCTGGAGGTTCT-3’ 5’-GACACAAGGCCTCCAACCT-3’ 193
MRC1 5’-CAAAACAAAGGGACGTTTCG-3’ 5’-CCTGCCACTCCAGTTTTCAT-3’ 116
18S 5’-GGCCCGAAGCGTTTACTT-3’ 5’-ACCTCTAGCGGCGCAATAC-3’ 173
Table 1. Nucleotide sequence for primers used for quantitative RT-PCR.
Table 2. Antibodies used for flow cytometry. 
Antigen Antibody Clone Vendor
CD3 IF4 BD Pharmingen
CD4 OX-35 BD Pharmingen
CD8α OX-8 BD Pharmingen
CD11b WT.5 BD Pharmingen
CD45 OX-1 BD Pharmingen
CD68 ED1 AbD Serotec
CD86 24F BD Pharmingen
CD163 ED2 AbD Serotec
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lar populations included the following: CD45+CD11b+ myeloid 
cells, CD45+CD11b+CD86+ M1-like cells, CD45+CD11b+CD163+ 
M2-like cells, CD3+CD4+, and CD3+CD8α+ T lymphocytes. 
CD45+CD11b+ cells were confirmed as >99% CD68+ in a 
separate control experiment. To determine the cell numbers 
of each myeloid cell population, the numbers of hematopoi-
etic cells were first determined by multiplying the percent-
age of CD45+ cells by the total number of viable cells recov-
ered from the respective defect. The cell numbers of myeloid 
cells were then determined by multiplying the percentage of 
CD11b+ cells by the total number of calculated hematopoietic 
cells. The cell numbers of M1- or M2-like cell populations 
were then determined by multiplying their percentage by the 
total number of calculated myeloid cells. The cell numbers 
of CD4+ and CD8+ lymphocyte populations were determined 
by first multiplying the percentage of CD3+ cells by the total 
number of viable cells followed by multiplying this number by 
the percentage of CD4+ or CD8α+ cells. All cell numbers were 
normalized per gram of excised muscle tissue.
Tibia histology
Histology was conducted on a set of rat tibiae at 28d 
post-injury. Bones were harvested from rats and fixed in 
10% neutral buffered formalin for a minimum of 7 days. 
Bones were then rinsed in water and decalcified for 7d in 
a formic acid bone decalcifier (Immunocal, Decal Chemi-
cal Corp, Tallman NY). Samples were processed in paraf-
fin and embedded in a longitudinal orientation. Bone was 
cut in 8 μm sections, deparafinized, and was stained with 
hematoxylin and eosin (H&E), trichrome, and safranin O 
by standard procedure. Sections were also stained with 
CD68 or CD3 primary antibodies with biotinylated IgG sec-
ondary antibody. Detection using 3,3’-diaminobenzidine 
(DAB) was performed to visualize the stain. For analysis, 
4 images (10x magnification) were taken in the osteotomy 
and callus region (not including the marrow cavity) of each 
sample. Three samples were analyzed for each group at 3 
and 14d. Images were converted to 8bit black and white 
images (ImageJ, NIH) and a threshold was set to include 
positively stained cells (evident with brown chromogen 
staining). Thresholds were applied to all images within 
a batch and ImageJ software was used to count positive 
cells.
Statistics
Dependent variables were analyzed using ANOVA or inde-
pendent samples t-tests. Post-hoc means comparisons test-
ing was performed when a significant ANOVA was observed. 
Alpha was set at 0.05. Statistical testing was performed with 
Prism 6 for Mac (Graphpad, La Jolla, CA, USA).
Figure 1. Traumatized muscle impairs bone healing after open fracture. Three-point bending mechanical testing and μCT imaging 
of tibiae were performed at 28 days post-injury. A) Contralateral tibia maximum load and stiffness were similar among groups and no 
significant difference was observed between contralateral and affected tibia of the SHAM group. Significant differences were detected 
among affected limb groups. † affected OST vs. contralateral OST & affected SHAM; * affected OST+VML vs. contralateral OST+VML & 
affected SHAM and OST groups (p-values <0.05). B) Representative μCT images of OST and OST+VML tibiae are presented from which 
callus volume was calculated; * p<0.05. Values are means ± SEM; n=4 – 6 per group. C) Histology of tibia of affected limb. Top, middle, 
and bottom rows: H&E, Masson’s Trichrome, and Safrinin O. Scale bars = 200 μm.
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Results
Severe muscle trauma impairs adjacent bone healing
A rat model of bone-muscle composite injury was inter-
rogated, in which the tibia and the overlying tibialis anterior 
(TA) muscle underwent osteotomy (OST) and VML injury, re-
spectively5. Tibia mechanical strength and stiffness (Figure 
1a) and bone volume within the fracture callus (Figure 1B) 
were reduced 28d post-injury in the presence of adjacent TA 
muscle VML injury. These findings are corroborated histo-
logically by the heightened presence of cartilage instead of 
woven bone within the fracture callus 28d post-injury (Figure 
1c). Overall, these findings indicate concomitant VML injury 
impairs adjacent tibia healing.
Severe muscle trauma invokes cellular recruitment 
As an initial assessment of immune cell infiltration follow-
ing VML injury, H&E sections of TA muscles were analyzed 
(Figure 2). TA muscles from OST groups presented mod-
est cellular infiltration and muscle fiber damage that was 
resolved by 28d post-injury following stereotypical muscle 
fiber repair25,26. Consistent with previous observations of iso-
Figure 2. VML injury leads to increased cellular infiltration to TA muscle. The TA muscle was isolated at 3, 14, and 28 days post-
trauma from SHAM, OST, and OST+VML groups. Tissue sections were stained with H&E. Representative images of TA cross-sections and 
magnified regions (inset black boxes) displaying overall muscle morphology and cellular recruitment were collected. Black arrows denote 
degenerating muscle fibers. n=4 per group. Black scale bars=1.0 mm and white scale bars=100 μm.
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lated VML injury3,27, OST+VML presented extensive cellular 
infiltration to the muscle defect 14d post-injury, which was 
partly reduced 28d post-injury.
Increased expression of genes involved in innate and adaptive 
immune responses in skeletal muscle following composite 
injury
The immune response in VML injured muscle was further 
compared to the modest, resolvable TA muscle fiber damage 
in OST groups 3d post-injury by PCR array. Clustergram anal-
ysis revealed that VML injury broadly upregulates expression 
of genes involved in innate and adaptive immune responses 
(Figure 3). More specifically, expression of genes involved in 
the acute phase response, inflammasome, pattern recogni-
tion receptors (PRRs), downstream components of intracellu-
lar signaling pathways, effector functions including cytokine/
chemokine production, and other innate genes trended to-
wards or were significantly up-regulated following OST+VML 
injury (Table 3). Moreover, gene expression of T-cell markers 
and adhesion molecules involved in T-cell-antigen presenting 
cell (APC) interaction trended towards or were significantly 
greater after OST+VML than OST-only. 
Heightened innate immune response consisting of a mixed 
M1/M2 macrophage phenotype is triggered in muscle tissue 
adjacent to a fracture
Initial immunofluorescence staining of TA muscle sec-
tions revealed increased recruitment of CD68+ mac-
rophages at 3 and 14 days post-trauma following OST+VML 
(Figure 4A). To accurately quantitate cellular recruitment 
over a longer period of time, flow cytometric analysis of 
cells isolated from the middle third of the TA muscle ad-
jacent to the tibia osteotomy was conducted through 28d 
post-trauma. Cells were initially gated for CD45+ hemat-
opoietic cells followed by CD11b+ myeloid cells that were 
determined to be CD68+ at 3d (data not shown) and ei-
ther CD86+ M1-like or CD163+ M2-like macrophages (Fig 
4B). Overall, the majority of the cells recruited following 
open fracture were CD45+CD11b+ myeloid cells (92.30 
+/-0.41%). At 3, 14, and 28d post-injury, OST+VML in-
jured muscles had 3.86, 6.77, and 6.50 times greater 
CD45+CD11b+ cells, respectively, than OST muscles (Fig-
ure 4C). The cell numbers of M1-like (CD11b+CD86+) to 
M2-like (CD11b+CD163+) macrophages in OST+VML versus 
OST groups were elevated through 28d (Figures 1D&E). 
Ratios (mean±SEM) of M1/M2 cell numbers were simi-
lar at 3d (0.86±0.08 vs. 0.85±0.12; p=0.97), but were 
higher at 14d (1.78±0.25 vs. 1.33±0.02; p=0.01) and 28d 
(3.25±0.53 vs. 2.10±0.18; p=0.09) post-injury, highlight-
ing a prolonged M1-like phenotype after open fracture 
(i.e., OST+VML). Gene expression analysis of M1 (CCR7 and 
iNOS) and M2 (ARG1, CD163, and MRC1) markers revealed 
a mixed M1/M2 response at 3 and 14 d post-trauma (Fig-
ure 4F). Collectively, these data show elevated and mixed 
recruitment of M1- and M2-like macrophages to TA muscle 
through 28d in animals that underwent OST+VML when 
compared to simple fracture.
Figure 3. Increased expression of genes involved in innate 
and adaptive immune responses following complex mus-
culoskeletal injury. Clustergram analysis displaying gene 
expression values in TA muscle tissue from naïve, OST, and 
OST+VML groups 3 d post-trauma as determined by PCR ar-
ray (PARN-052Z, SABiosciences). n=3 per group. Magnitude 
of gene expression is depicted by color. Green represents re-
duced expression, black represents no change, and red repre-
sents increased expression according to the average value of 
the gene in all samples. 
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Figure 4. Heightened and prolonged recruitment of innate immune cells displaying mixed M/M2 phenotype within VML injured 
muscle. The TA muscle was isolated from OST, OST+VML, and specified control groups at indicated times post-injury (TPI) for A) immu-
nofluorescence, B-E) flow cytometric, and F) transcriptional analyses. A) For immunofluorescence analysis tissue sections were stained 
for laminin, CD68, and nuclei (DAPI); n=4 per group. Scale bars=50 μm. B) For flow cytometric analysis, the middle third of the TA muscle 
that contains the defect and neighboring area was collected, digested, and cellular content isolated. Muscle-derived cells were labeled 
with antibodies to identify myeloid cells and analyzed by flow cytometry. To identify pro- and anti-inflammatory myeloid cells, populations 
were initially gated (red polygon) to exclude cell debris and doublets. Selected single cell populations were gated based on CD45 expres-
sion, followed by CD11b to identify myeloid cells. Pro- and anti-inflammatory myeloid cells were subsequently gated (black bar) based 
on their expression of CD86 or CD163, respectively. Gates were established by fluorescence-minus-one plus isotype controls. Relative 
cell numbers of C) CD45+CD11b+ myeloid cells, D) CD45+CD11b+CD86+ pro-inflammatory myeloid cells, and E) CD45+CD11b+CD163+ anti-
inflammatory myeloid cells were determined. Dashed-lines represent average cell numbers detected within contralateral control tissue. 
Data are normalized per gram of tissue and presented as mean ± SEM. n=4 per group. *P<0.05 versus OST group. (F) Gene expression 
of M1 (CCR7 and iNOS) and (F) M2-like (ARG1, CD163, and MRC1) macrophage markers were determined in TA muscle was isolated from 
OST and OST+VML groups at 3 and 14 days post-trauma by qPCR. Tissue isolated from contralateral TA muscle was used to normalize 
data. Data are presented as mean ± SEM. *P<0.05 versus OST group.
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Figure 5. VML injury triggers increased recruitment of T helper and cytotoxic lymphocytes to muscle defect region. The TA muscle was 
isolated from OST, OST+VML, and specified control groups at indicated times points for flow cytometric analysis. A) To identify T lympho-
cytes (red polygon), samples were gated to exclude debris and doublets (as previously described), followed by gating for CD3 expression. 
CD3+ cells were gated based on CD4 and CD8α expression to identify T helper and cytotoxic lymphocytes, respectively. Cells were analyzed 
by flow cytometry for B) CD3+CD4+ and C) CD3+CD8+ expression. Dashed-lines represent average cell numbers detected within contralateral 
control tissue. Data are normalized per gram of tissue and presented as mean ± SEM. n=4 per group. *P<0.05 versus OST group. 
Figure 6. VML injury directly influences immune responses in the adjacent fracture callus. Affected tibiae from OST and OST+VML 
groups were harvested 3 and 14d post-injury for immunohistological analysis of CD68+ macrophage and CD3+ T-lymphocyte infiltration 
in the fracture callus. A & C) Representative images from the callus region for each group are presented. Scale bars=100 μm. (B & D) 
The number of CD68+ and CD3+ cells present in the callus was quantified from immunohistological sections. *p<0.05 vs. OST & OST+VML 
within the respective time point. Values are means ± SEM; n=3 per group. 
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Table 3. Transcriptional fold changes of innate and adaptive genes following OST and OST+VML injuries.
INNATE IMMUNE RESPONSE
Pattern Recognition Receptors (PRRs) and Co-receptors 
Gene OST OST+VML p-value
CD14 53.27±7.99 101.41±18.76 0.08
DDX58 (RIG-1) 3.65±0.57 8.16±0.97 0.001
NOD2 11.14±1.25 29.9±10.14 0.14
TLR1 59.27±10.39 114.15±15.9 0.04
TLR2 92.39±11.39 227.31±18.77 0.004
TLR3 0.86±0.12 0.99±0.15 0.56
TLR4 7.61±0.38 12.78±0.06 0.0002
TLR5 9.72±0.47 11.73±1.04 0.15
TLR6 4.9±0.3 9.59±0.94 0.01
TLR7 12.02±1.66 17.66±1.79 0.08
TLR9 2.88±0.08 4.81±1.27 0.2
Signaling Molecules and Transcription Factors
Gene OST OST+VML p-value
IRAK1 4.19±0.23 5.69±0.34 0.02
IRF-3 3.21±0.31 5.22±0.7 0.06
IRF-7 2.8±0.22 6.7±1.12 0.03
Jak2 4.39±0.34 7.06±0.61 0.02
Jun 2.14±0.91 1.87±0.14 0.78
Mapk1 1.71±0.55 2.09±0.14 0.54
Mapk3 3.12±0.2 6.2±1.38 0.09
Mapk8 3.43±0.26 3.03±0.3 0.37
Mapk14 1.21±0.16 1.16±0.17 0.85
MYD88 12.97±0.99 25.71±2.9 0.01
NFKB1 3.22±0.29 6.13±0.5 0.01
NFKBIA 1.28±0.11 2.02±0.03 0.003
Stat1 4.19±0.64 5.06±0.63 0.39
Stat4 2.41±0.76 4.26±0.82 0.17
Stat3 19.58±1.87 25.49±3.3 0.19
Stat6 15.08±2.3 33.42±5.87 0.04
TRAF6 2.14±0.04 3.19±0.04 0.0001
Cytokine/chemokine and Related Receptors
Gene OST OST+VML p-value
CCL12 33.26±10.22 47.74±7.9 0.32
CCR5 36.94±5.72 51.64±7.63 0.2
CCL3 2.4±0.85 11.85±5.04 0.14
CCL5 (RANTES) 1.39±0.21 1.18±0.09 0.42
CSF2 7.28±2.36 4.64±0.86 0.35
CXCL10 2.27±0.69 4.54±1.13 0.16
Ifngr1 24.94±3.74 51.63±6.2 0.02
IL1A 0.36±0.05 1.03±0.28 0.08
IL1R1 9.18±0.66 22.45±1.08 0.0005
IL6 142.3±24.7 278.99±36.59 0.04
CXCR3 2.33±0.57 2.28±0.97 0.97
IFNAR1 0.68±0.21 1.32±0.09 0.05
TNF 7.06±2.88 20.43±5.84 0.11
Acute-phase Response
Gene OST OST+VML p-value
C3 17.65±0.68 32.65±11.89 0.28
C5AR1 21.38±4.41 68.65±10.9 0.02
CAMP 4.62±2.69 19.21±15.5 0.41
CRP 2.55±0.41 1.58±0.36 0.15
LBP 21.97±2.69 14.79±1.91 0.09
Inflammasome
Gene OST OST+VML p-value
NLRP3 15.11±0.87 33.02±0.3 0.00004
IL1B 9.27±1.22 35.3±15.19 0.16
IL18 43.56±15.87 72.93±2.29 0.14
Casp1 2.42±0.01 3.97±0.74 0.1
Casp8 3.09±0.04 4±0.35 0.06
Unclassified
Gene OST OST+VML p-value
MX2 1.36±0.48 2.7±0.66 0.18
ITGAM (CD11b) 89.12±18.99 205.71±8.14 0.005
Lyz2 69.25±21.81 113.48±25.62 0.26
SLC11A1 34.37±13.99 129.43±24.34 0.03
MPO 3.72±3.32 53.39±48.03 0.36
Faslg 0.95±0.12 2.02±0.15 0.01
ADAPTIVE IMMUNE RESPONSE
T lymphocytes - Activation and Adhesion Molecules
Gene OST OST+VML p-value
CD1D1 0.39±0.02 0.32±0.07 0.44
CD4 19.16±2.27 27.8±2.67 0.07
CD40 7.22±0.29 16.55±2.51 0.02
CD40LG 3.18±0.97 3.37±1.24 0.91
CD8A 28.43±4.33 116.96±19.67 0.01
CD80 11.33±1.16 20.6±1.67 0.01
CD86 28.24±2.73 50.37±18.06 0.29
ICAM1 5.39±0.84 10.04±0.37 0.01
IL2 119.51±88.48 63.96±23.72 0.58
IL23A 0.9±0.37 0.6±0.05 0.47
T lymphocyte Phenotype - Th1/Th2/Th17/Treg
Gene OST OST+VML p-value
CCR6 5.82±0.66 10.16±2.94 0.22
Foxp3 0.43±0.04 0.73±0.1 0.06
GATA3 0.06±0.01 0.04±0.02 0.4
IFN-g 6.19±2.86 2.79±1.45 0.35
IL4 0.31±0.03 0.24±0.11 0.61
IL10 0.49±0.14 0.67±0.03 0.27
IL13 0.27±0.08 0.29±0.11 0.86
RORC 0.28±0.05 0.1±0.02 0.04
Tbx21 (Tbet) 0.82±0.11 0.83±0.24 0.97
BOLD p<0.05, Student’s t-test of OST vs. OST+VML;  
Values are means ± SEM.
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Complex musculoskeletal injury triggers increased recruit-
ment of T helper and cytotoxic lymphocytes in adjacent soft 
tissue
The role of the adaptive immune response in sterile 
wound healing is an active area of research28-30. While ani-
mals that lack functional B and T lymphocytes display im-
proved fracture healing31, indicating an inhibitory response 
in bone regeneration, in skeletal muscle the adaptive im-
mune response appears to be beneficial to regeneration 
in healthy mice but detrimental in dystrophic mice32. Flow 
cytometric analysis was carried out on cells isolated from 
the TA muscle, which were gated for CD3+ T lymphocytes 
followed by CD4+ and CD8+ T lymphocyte markers (Fig-
ure 5A). At 3, 14, and 28d following trauma, CD3+CD4+ 
T lymphocytes were 3.83, 6.35, and 2.85-times higher, 
respectively, in OST+VML than OST muscles. At the same 
time points, CD3+CD8+ T lymphocytes were 3.95, 6.56, 
and 2.91-times higher, respectively, in the VML defect re-
gion of the OST+VML group compared to the OST group 
(Figures 5B&C). The OST+VML group displayed CD3+CD4+/
CD3+CD8+ ratios (mean ±SEM) of 3.79±0.28, 2.02±0.42, 
and 2.11±0.28 at 3, 14, and 28d post-trauma, respective-
ly. These ratios were similar compared to the OST group 
and indicate that initially CD4+ T cells comprise a larger 
portion of the T lymphocyte population, but at later time 
points there is a progressive increase in the proportion of 
CD8+ T cells recruited to the site of injury. Altogether open 
fracture promoted a heightened and prolonged innate and 
adaptive inflammatory response through the initial 28d 
post-injury.
Macrophage and T-lymphocyte recruitment to fracture callus 
is exacerbated by muscle trauma 
The immune response to traumatized bone is crucial to re-
generation, but can be deleterious if unbalanced or temporal-
ly disrupted33. Within the callus region, CD68+ macrophages 
were similar among all groups 3d post-injury, but were sig-
nificantly elevated 14d post-injury in non-repaired OST+VML 
tibia (Figures 4A&C). Meanwhile, CD3+ cells were significantly 
elevated 3d post-injury after OST+VML, but were similar 
among all groups 14d post-injury (Figures 4B&D). These find-
ings suggest that heightened inflammation within VML injured 
muscle directly influences immune cell infiltration within the 
adjacent fracture callus.
Discussion
The immune response to isolated injuries of muscle or 
bone is known to play a fundamental role in their regenera-
tion19,34. In the context of complex fractures, investigations 
of the cellular components and dynamics of the ensuing in-
flammatory response have almost completely focused on the 
fracture site, with very little attention given to the surround-
ing traumatized musculature. Yet, the incidence of delayed 
and non-union rates is greatest in fracture cases that pre-
sent complex injuries that often involve significant trauma 
or loss of surrounding muscle tissue10,21. Moreover, sterile 
“open fracture” studies in animal models unequivocally dem-
onstrate that targeted irrecoverable muscle injury (i.e., volu-
metric muscle loss) or whole muscle ablation delays fracture 
healing via mechanisms unrelated to revascularization11-15,35. 
The current study corroborates with these earlier findings, 
demonstrating that TA muscle VML injury impaired fractured 
tibia healing in the otherwise healthy male Lewis rat. We ob-
served heightened and prolonged myeloid and lymphocyte 
infiltration with the VML injured tissue and the adjacent tibia 
fracture callus, making it plausible that the VML injury trig-
gered a dysregulated immune response that impaired frac-
ture healing. These findings are in line with other conditions 
in which comorbid heightened inflammation is associated 
with impaired fracture healing16-20,24. The current findings 
therefore broadly identify the immune response to trauma-
tized muscle, particularly VML injury, as a potential thera-
peutic target for advancement of open fracture orthopaedic 
care. These initial findings are significant because current 
clinical practice lacks targeted therapeutics for the systemic 
or local impact of traumatized skeletal muscle inflammation 
on musculoskeletal healing.
Volumetric muscle loss presents distinct injury character-
istics that challenge mammalian skeletal muscle regenera-
tion. Prolonged outcomes of VML include extensive fibrosis 
and chronic losses of muscle fibers, strength, and joint range 
of motion3,5,6. In contrast, other forms of muscle trauma in 
rodent models, such as eccentric-, crush-, freeze-, and toxin-
induced injuries typically endogenously regenerate and fully 
recover muscle strength26,36-38. Regeneration among these 
recoverable injuries is partly modulated by the amplitude and 
dynamics of a predominantly innate immune response34,39-42. 
As an example, the osteotomy-only group presented muscle 
injury (likely caused by surgery) that regenerated in tandem 
with a typical canonical immune response, which has been 
characterized for recoverable eccentric and freeze injury34,43. 
Comparatively, VML injury (≈20% loss of TA muscle) incited 
an amplifed, prolonged, and progressively pro-inflammatory 
innate and adaptive immune response. It is possible that the 
inflammatory response following VML injury was triggered 
by a heightened release of endogenous danger-associated 
molecular patterns (DAMPS) from damaged muscle fibers44, 
which are recognized by TLRs and the inflammasome and 
initiate cell signaling pathways that drive inflammatory re-
sponses that include the production of proinflammatory cy-
tokines. In support, TA muscle transcript levels for several 
PRRs (TLR2 and TLR4), the inflammasome (NLRP3) and pro-
inflammatory cytokines (IL-1, IL-6 and TNF-α) were elevated 
in VML injured compared to canonically healing muscle in 
osteotomy-only rats. Given that other recoverable muscle in-
juries, such as crush and ischemia-reperfusion13,45, have not 
impaired fracture healing, it would appear either the sheer 
magnitude or composition of the immune response to VML 
injury is a primary determinant of musculoskeletal healing.
The cellular immune response to VML overwhelmingly con-
sisted of macrophages, which has been highly characterized in 
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wound healing and shown to play phenotype-specific roles46. 
Classically activated, proinflammatory M1 macrophages di-
rectly facilitate wound repair by participating in the initial 
inflammatory response as debris/cell clearing phagocytes, 
produce reactive oxygen species (ROS) and proinflammatory 
cytokines (IL-1, IL-6, and TNF-α), and support a proinflamma-
tory T helper cell phenotype (Th1). The alternative phenotype 
(M2) contributes to wound resolution by production of anti-
inflammatory molecules (IL-4, IL-10, IL-13, IL-1R antagonist, 
decoy IL-1 receptor type II) and growth factors (VEGF, TGF-β, 
and IGF-1) and supports an anti-inflammatory T helper 2 (Th2) 
phenotype46,47. Temporal macrophage polarization is critical 
for successful wound healing, wherein prolonged M1 or early 
M2 responses result in poor regenerative outcomes. In addi-
tion, in vivo phenotypes are more diverse than general M1/M2 
phenotypes and likely influenced by the type and/or level of 
injury. For example, following skeletal muscle laceration mice 
presented early transcriptional upregulation and macrophage 
surface marker expression were indicative of a mixed M1/M2 
phenotype, suggesting severe muscle injury does not trigger 
canonical macrophage polarization48. Our data are in agree-
ment in that complex musculoskeletal trauma involving VML 
injury does not trigger canonical polarization, as we also ob-
served a mixed M1/M2 phenotype through day 28 based on 
CD86 (M1) and CD163 (M2) markers. We speculate that the in-
ability to properly polarize local macrophages to the required 
phenotypes at the required times or extending presence of M1 
macrophages impairs complex musculoskeletal healing partly 
by extending the inflammatory phase and delaying the repair 
and remodeling phases of bone healing. As support, Grundnes 
and Reikeraas showed that fracture healing was impaired fol-
lowing local macrophage activation with glucan, a proinflam-
matory molecule49. 
While the macrophage response to muscle injuries is well-
studied, the T cell response is poorly characterized. We ob-
served that VML injury induced an amplified and prolonged 
recruitment of CD4+ and CD8+ T lymphocytes within the trau-
matized musculature, as well as elevated gene expression of 
co-stimulatory molecules required for lymphocyte activation 
and infiltration. It is unknown if this response is non-specific 
(inflammatory) or antigen-specific. In sterile recoverable 
muscle injuries, antigen specific CD8+ T cell responses are 
promptly regulated50, although it is possible that a severe or 
persistent injury may incite an antigen-based CD8+ T cell re-
sponse34. In other muscle-based pathologies including poly-
myositis and Duchenne muscular dystrophy, there is marked, 
prolonged T lymphocyte infiltration and activity, raising the 
potential that VML injury possesses characteristics akin to a 
myopathic condition34,51. Notably, VML injury also resulted in 
elevated T lymphocytes in the adjacent fracture callus, which 
has previously been associated with impaired fracture heal-
ing31. For example, CD8+ T cell recruitment and terminal dif-
ferentiation in fracture hematomas are associated with im-
paired healing28,52, while depletion improved bone repair53. 
Impaired musculoskeletal healing may be due to modulation 
of various activation and effector functions of CD8+ T cells 
including polarization (cytokine production), cell lysis via per-
forin and granzyme B, and cellular interactions. We therefore 
hypothesize that VML injury prompts a CD8+ T cell response 
that impairs musculoskeletal regeneration that may be effec-
tively targeted by immunomodulatory therapies. 
Similar to CD8+ T cells, we show CD4+ T cells were recruit-
ed at increased numbers through 28 d following OST+VML. 
Although depletion studies in normal fracture healing sug-
gest a beneficial effect53, literature also suggests that during 
pathologies (arthritis, infection, cancer) CD4+ T lymphocytes 
are detrimental in bone repair processes54. Whether CD4+ T 
cells are beneficial or detrimental to fracture repair likely de-
pends on the magnitude and duration of T cell recruitment, 
T helper cell polarization (Th1/Th2/Th17) and production of 
pro- or anti-inflammatory cytokines. For example, T helper 
polarization impacts osteoblasts and osteoclasts and influ-
ence cellular activation and function, all which can indirectly 
uncouple the bone repair process54. Lymphocytes can also 
directly impair fracture healing by the release of soluble fac-
tors including RANKL, which activate osteoclasts as well as 
direct cell-to-cell (CD40-CD40L) contact of stromal cells, 
which impact RANKL and OPG levels54. Impaired healing 
could also be tied in to the recruitment, or lack of T regula-
tory cells (Tregs). Tregs make up a small percentage of CD4+ 
T lymphocytes and modulate the immune response by anti-
inflammatory mechanisms (IL-10, TGF-β, direct cell-to-cell 
interactions). Recently, Tregs have been shown to infiltrate 
injured muscle and secrete amphiregulin, which was required 
for successful muscle repair55. Additionally, Tregs modulate 
regeneration following recoverable toxin injury via a puta-
tive interaction with resident satellite cells29. We found tran-
scriptional expression of Foxp3, the master regulator of Treg 
development and function, was not significantly upregulated 
in injured muscle following complex musculoskeletal injury. 
These differences suggest Treg induction/recruitment and 
amphiregulin production may be low following complex mus-
culoskeletal injury and partly explain impaired healing. It is 
essential that future studies are carried out to evaluate the 
impact of modulating T lymphocyte recruitment, activation, 
polarization, and secretion of factors (e.g., amphiregulin) in 
both traumatized muscle and bone to favor tissue repair. 
The current data provide the most extensive characteriza-
tion of the immune response to VML injury to date. As predict-
ed by the irrecoverable nature of VML, the ensuing immune 
response deviates from that described for canonical muscle 
regeneration. Notably, VML presents a prolonged mixed M1/
M2 response and heightened lymphocyte infiltration that re-
sembles pathological muscle tissue. The data indicate that 
VML results in heightened macrophage and lymphocyte infil-
tration within the fracture callus of adjacently fractured bone 
and impairs fracture healing. It is important to note that this 
rat model of open fracture did not include blunt trauma, and 
it is likely that the magnitude and temporal characteristics of 
the dysregulated immune response to VML are further ex-
acerbated in the clinic56. We posit that VML presents various 
targets that may be targeted by immunomodulatory thera-
pies for the improvement of bone and muscle regeneration 
following complex musculoskeletal injuries. 
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